Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
    • Cancer Business Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
    • YouTube Channel
  • Contact Us

Annual Reports

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • Financial Reports

  • Annual Reports
  • Quarterly Reports
Filter Filings:
Date Form Description Docs XBRL Pages
01/29/01 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23.1
HTML PDF 35
01/28/00 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-10.13
EX-21
EX-23.1
EX-27
EX-99.1
HTML PDF 60
03/31/99 10-K/A Annual report pursuant to section 13 and 15(d) HTML PDF 13
01/29/99 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-21
EX-23.1
EX-27
HTML PDF 42
01/29/98 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-21
EX-23.1
EX-27
HTML PDF 40
01/29/97 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-23.1
EX-27
EX-99.1
HTML PDF 35
01/29/96 10-K405 Annual report [Sections 13 and 15(d), S-K Item 405]
Related Documents
EX-10.31
EX-23.1
EX-27
HTML PDF 44
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Sep 19, 2023

Anixa Biosciences Establishes Cancer Business Advisory Board

Read More...
Aug 31, 2023

Anixa Biosciences to Participate in September Investor Conferences

Read More...
Aug 28, 2023

Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial

Read More...
Copyrights © 2023 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap